Biomarkers of toluene diisocyanate and thermal degradation products of polyurethane, with special reference to the sample preparation

Analytica Chimica Acta

Volumn 333, Issue 3, 1996, Pages 277-283

  Lind, P ^a   Skarping, G ^a   Dalene, M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biomarkers; Gas chromatography mass spectrometry; MDI; PUR; TDI; Thermal degradation

Indexed keywords

ISOCYANIC ACID DERIVATIVE; POLYURETHAN; TOLUENE DIISOCYANATE; UREA DERIVATIVE; URETHAN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG URINE LEVEL; FRACTIONATION; HUMAN; HUMAN TISSUE; HYDROLYSIS; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TECHNIQUE;

EID: 0030575922     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-2670(96)00291-7     Document Type: Article

References (27)

1. [1] G. Skarping and M. Dalene, J. Chromatogr. B, 663 (1995) 209.
2. [2] G. Skarping, M. Dalene and P. Brunmark, Chromatographia, 30 (1994) 619.
3. [3] A.L. Kennedy and W.E. Brown, Occupational Medicine: State of the Art Review, Vol. 7, Hanley and Belfus, Philadelphia PA, 1992 p. 301.
4. [4] M. Littorin, L. Truedsson, H. Welinder, G. Skarping, U. Mårtensson and A.G. Sjöholm, Scand. J. Work Environ. Health, 20 (1994) 216.
5. [5] G. Skarping, M. Dalene, B.G. Svensson, M. Littorin, B. Åkesson, H. Welinder and S. Skerfving, Occup. Environ. Med., 53 (1996) 180.
6. [6] O. Vandenplas, J.L. Malo, M. Saetta, C.E. Mapp and L.M. Fabbri, Br. J. Ind. Med., 50 (1993) 213.
7. [7] H. Tinnerberg, M. Spanne, M. Dalene and G. Skarping, Analyst, 121 (1996) 1101.
8. [8] M. Dalene, L. Mathiasson, G. Skarping, C. Sangö and J.F. Sandström, J. Chromatogr., 435 (1988) 469.
9. [9] G. Skarping, L. Renman, C. Sangö, L. Mathiasson and M. Dalene, J. Chromatogr., 346 (1985) 191.
10. [10] G. Skarping, M. Dalene and H. Tinnerberg, in preparation.
11. [11] M. Spanne, H. Tinnerberg, M. Dalene and G. Skarping, Analyst, 121 (1996) 1095.
12. [12] G. Skarping, M. Dalene and P. Lind, J. Chromatogr. A, 663 (1994) 199.
13. [13] J.F. Sandström, G. Skarping and M. Dalene, J. Chromatogr., 479 (1989) 135.
14. [14] P. Persson, M. Dalene, G. Skarping, M. Adamsson and L. Hagmar, Br. J. Ind. Med., 50 (1993) 1111.
15. [15] P. Lind, M. Dalene, G. Skarping and L. Hagmar, Occup. Environ. Med., 53 (1996) 94.
16. [16] A. Maitre, M. Berode, A. Perdrix, S. Romazini and H. Savolainen, Int. Arch. Occup. Environ. Health, 65 (1993) 97.
17. [17] G. Skarping, M. Dalene and M. Littorin, Int. Arch. Occup. Environ. Health, 67 (1995) 73.
18. [18] M. Dalene, G. Skarping and P. Lind, in press..
19. [19] D. Schütze, O. Sepai, J. Lewalter, L. Miksche, D. Henschler and G. Sabbioni, Carcinogenesis, 16 (1995) 573.
20. [20] C. Rosenberg and H. Savolainen, J. Chromatogr., 367 (1986) 385.
21. [21] C. Rosenberg and H. Savolainen, J. Chromatogr., 323 (1985) 429.
22. [22] C. Rosenberg and H. Savolainen, J. Chromatogr., 358 (1986) 385.
23. [23] A.L. Tiljander, G. Skarping and M. Dalene, J. Liq., Chromatogr., 13 (1990) 803.
24. [24] H. Ozawa, J. Biochem., 62 (1967) 419.
25. [25] C.S. Ted Tse and A.J. Pesce, Toxicol. Appl. Pharmacol., 51 (1979) 39.
26. [26] P. Brunmark, M. Dalene and G. Skarping, Analyst, 120 (1995) 41.
27. [27] A.L. Kennedy, L. Lastbom, G. Skarping, M. Dalene, A. Ryrfeldt, P. Moldeus and W.E. Brown, Chemico-Biological Interactions, 98 (1995) 167.